Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Bristol Myers Squibb Company (BMY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Bristol Myers Squibb Company (BMY) - free report >>
Image: Bigstock
J&J to Buy Vogue for ~$3.3B, Boost Hair Care Portfolio
Johnson & Johnson (JNJ - Free Report) announced that Johnson & Johnson Consumer Inc. has entered into a definitive agreement under which it will acquire a privately held company Vogue International in a deal worth about $3.3 billion in cash. Based in Florida, Vogue is focused on the marketing, development and distribution of salon-influenced and nature inspired hair care and other personal care products.
The proposed acquisition will give Johnson & Johnson a full line of leading advanced hair care products including the OGX collection of shampoos, conditioners, treatments, styling products, body care and bath products, the FX line of hair styling products, and the Proganix and Maui Moisture hair care lines.
The acquisition is slated to close in the third quarter of 2016 and is not expected to impact Johnson & Johnson’s sales or earnings guidance for 2016 that was announced with first-quarter 2016 results.
We are positive on the deal. The Vogue acquisition is in line with Johnson & Johnson’s strategy of strengthening its global presence in the hair care category and will also complement the company’s existing Consumer portfolio.
Johnson & Johnson’s Consumer business currently has three $1 billion brands. The company expects to expand that to five $1 billion brands by 2020. The company has been working on prioritizing and investing in key Consumer areas including baby care, skin care and over-the-counter products and has been striking deals to augment the segment further.
This April, it announced its intention to acquire a privately held company NeoStrata, in a bid to boost its skin care portfolio. Financial terms of the agreement were undisclosed and the transaction is expected to close in the first half of 2016.
Johnson & Johnson is a Zacks Rank #2 (Buy) stock. Some favorably ranked stocks in the health care sector include Pfizer Inc. (PFE - Free Report) , Bristol-Myers Squibb Company (BMY - Free Report) and Retrophin, Inc. . All three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>